Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001185185-24-000231
Filing Date
2024-03-12
Accepted
2024-03-12 17:09:39
Documents
1
Period of Report
2024-03-12

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2097
  Complete submission text file 0001185185-24-000231.txt   3556
Mailing Address 10224 FALLS ROAD POTOMAC MD 20854
Business Address 10224 FALLS ROAD POTOMAC MD 20854 301-983-0998
IGC Pharma, Inc. (Issuer) CIK: 0001326205 (see all company filings)

EIN.: 202760393 | State of Incorp.: MD | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 114 EAST MONTGOMERY STREET BALTIMORE MD 21230
Business Address
LIERMAN TERRY L (Reporting) CIK: 0002014677 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32830 | Film No.: 24743257